DALLAS, Nov. 10, 2023 — A new calculator estimates a person’s risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the ...

Please provide your email address to receive an email when new articles are posted on . A cohort of predominantly Hispanic women receiving Medicaid may be at higher CV risk during pregnancy than a ...

A new risk calculator encompassing the full spectrum of cardiovascular, kidney, and metabolic risk factors can estimate both the 10- and 30-year risks of MI, stroke, and heart failure for a broad ...

Female reproductive factors minimally impacted cardiovascular disease risk prediction models. Only female-specific factors as a group, not individually, were linked with marginal improvements in risk ...

A recently unveiled cardiovascular disease risk calculator that measures a patient’s risk for heart attack and stroke is better calibrated and more precise than its previous version, but if current ...

A new calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to ...

A new online tool based on the PREVENT equations offers detailed population-based estimates of cardiovascular risk out to 30 years in younger adults, with the predictions stratified by age and sex.

“But this is the first time percentiles have been translated and applied to long-term risk for heart disease. When a patient ...

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition ...

Researchers used advanced machine learning to increase the accuracy of a national cardiovascular risk calculator while preserving its interpretability and original risk associations. Risk calculators ...

Please provide your email address to receive an email when new articles are posted on . Use of a new risk calculator could reduce eligibility for statins and BP drugs by nearly 16 million U.S. adults.

Population-based cardiac screening tools fail to identify many patients at risk for a first acute coronary syndrome event.